you are speculating and making guesses on an anonymous forum based on what you think is happening ... i'd prefer to take the guidance of management that comes with the surity that they are required to keep the market informed. They haven't said fda approval won't be delayed or that it won't take time. They have said they are confident of approval. That, the peer acknowledgements of the isn technology, the thousands of hours of R&d and and the reality that US authorities see mobile health as a good way of improving their system and reducing hospital stays says to me that they have a saleable, scalable product.
Based on the fact I'm well north of six noughts to the good since your sell calls a year ago, forgive me for calling it as i see it.
ISN Price at posting:
37.5¢ Sentiment: Buy Disclosure: Held
